Polycythemia vera

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

2FDA treatments

20Recruiting trials

Regulatory Watchboard

10 events

Jun 2026A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

Ono Pharmaceutical Co. Ltd — PHASE3

TrialNOT YET RECRUITING

Feb 2026A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV

Duan Minghui — NA

TrialNOT YET RECRUITING

Jan 2026Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter Study

Federico II University

TrialNOT YET RECRUITING

Jan 2026Potential Biological and Physiological Determinants for Exercice in Patients With Polycythemia Vera

Hospices Civils de Lyon — NA

TrialNOT YET RECRUITING

Sep 2025MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

MPN Research Foundation — NA

TrialRECRUITING

Sep 2025Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera

Chengdu Zenitar Biomedical Technology Co., Ltd — PHASE2

TrialRECRUITING

Aug 2025A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

Disc Medicine, Inc — PHASE2

TrialRECRUITING

Jun 2025Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV)

BeBetter Med Inc — PHASE1

TrialNOT YET RECRUITING

May 2025Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History

Fondazione Policlinico Universitario Agostino Gemelli IRCCS — NA

TrialNOT YET RECRUITING

Dec 2024Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly

iOMEDICO AG

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

2

Total programs

1

Open now

1

Copay cards

1

Travel grants

Copay Assistance1

BESREMi

PharmaEssentia

OpenContact for detailsApply ↗

Travel Grants1

Susan Lang Pay-It Forward Patient Travel Assistance Programs

Leukemia & Lymphoma Society

Contact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

2 FDA-approved

Besremi

(ropeginterferon alfa-2b-njft)Orphan drug

PharmaEssentia

Interferon alfa-2b [EPC]

12.1 Mechanism of Action Interferon alfa belongs to the class of type I interferons, which exhibit their cellular effects in polycythemia vera in the ...

Approved Nov 2021FDA label ↗

JAKAFI

(RUXOLITINIB)Orphan drugstandard

Incyte Corporation

View full treatment details on disease page →

Clinical Trial Landscape

20 active trials

7Phase 3

5Phase 2

1Phase 1

1N/A

5Unknown

1PHASE1, PHASE2

20Total recruiting

Search clinical trials for Polycythemia vera →

Recent News & Research

No recent news articles indexed yet for Polycythemia vera.
Search PubMed for Polycythemia vera →

Browse all Polycythemia vera news →

Specialist Network

Top 6 by expertise

Jean-Jacques Kiladjian

(France) Clinical Investigations Center, Saint-Louis Hospital, Paris, France

Score 421 trial3 pubs

Claire Harrison

Acting on behalf of the Sponsor (UK), Guy's Hospital, London, UK, SE1 9RT

Score 401 trial24 pubs

Jingjing Zhang, M.D

PharmaEssentia

📍 PHILADELPHIA, PA

Score 381 trial1393 pubs

Gabriela Hobbs, MD, MD

Massachusetts General Hospital

📍 BOSTON, MA

Score 384 trials1 pub

Jean-Jacques Kiladjian, MD

PV-Nord

Score 341 trial

Anand A Patel

City of Hope Comprehensive Cancer Center LAO

Score 141 trial256 pubs

View all Polycythemia vera specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles